See all locations for this study
Phase 3Recruiting

Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research

Sponsored by Oculis

About this study

The goal of this clinical trial is to evaluate the safety and efficacy of privosegtor, a neuroprotective candidate, in patients diagnosed with optic neuritis (ON). Researchers will compare privosegtor and the standard of care (methylprednisolone) to a placebo and standard of care (methylprednisolone).

Enrolling at this location

UT Southwestern Medical Center (Ophthalmology CRU)

Dallas, Texas

I'm interested

This study also enrolls at 3 other locations. See all.

Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.

Trial data sourced from ClinicalTrials.gov.